Page last updated: 2024-08-21

adamantane and tamoxifen

adamantane has been researched along with tamoxifen in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alworth, WL; Eshete, M; Nikov, GN; Rajnarayanan, RV1
Borek-Dohalská, L; Frei, E; Hodek, P; Mráz, J; Stiborová, M1
Nose, T; Shimohigashi, Y; Tokunaga, T1

Other Studies

3 other study(ies) available for adamantane and tamoxifen

ArticleYear
Interactions of synthetic estrogens with human estrogen receptors.
    The Journal of endocrinology, 2001, Volume: 170, Issue:1

    Topics: Adamantane; Binding, Competitive; Diethylstilbestrol; Estradiol; Estradiol Congeners; Estrogen Receptor alpha; Estrogen Receptor beta; Fluorescence Polarization; Humans; In Vitro Techniques; Models, Molecular; Phenols; Protein Binding; Receptors, Estrogen; Tamoxifen

2001
New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen.
    Archives of biochemistry and biophysics, 2002, Jul-01, Volume: 403, Issue:1

    Topics: Adamantane; Amantadine; Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme Inhibitors; DNA Adducts; Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Kinetics; Microsomes; Models, Chemical; Mutagens; Oxygen; Rabbits; Steroid Hydroxylases; Tamoxifen

2002
Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
    Toxicology letters, 2009, Dec-01, Volume: 191, Issue:1

    Topics: Adamantane; Diethylstilbestrol; Endocrine Disruptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Ligands; Luciferases; Models, Molecular; Phenols; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen

2009